Skip to content

Public FDA record

Z-0068-2019: Retrograde Cardioplegia Cannula, Model Number RMG-0015S The Retrograde Cardioplegia Cannula is intended

Recall record Z-0068-2019 for Surge Medical Sales, LLC (DBA Surge Cardiovascular). View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0068-2019
Company in FDA record
Surge Medical Sales, LLC (DBA Surge Cardiovascular)
FDA record creation date
Oct 4, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The device was built with the rigid insertion stylet instead of the flexible stylet.

Source facts

Action
The firm, MediSurge, contacted its customer via email on 7/18/18. The email described the product, problem and actions to be taken. If you have any questions, contact Director of Quality Assurance/Regulatory Affairs, at 616-202-6120 or email: kjonas@allianthealthcare.com.
Initiated
2018-07-18
Root cause
Nonconforming Material/Component
Terminated
2019-04-04
Distribution
US Distribution to state of: SC.
Recall number
Z-0068-2019
Recall status
Terminated
CDRH record ID
167337
FDA record created
2018-10-04
Recall event number
81042

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗